BridgeMD
New treatment option for Adult Patients Undergoing CABG
Official title Effect of Preoperative Stellate Ganglion Block on Postoperative Atrial Fibrillation After Coronary Artery Bypass Grafting
ClinicalTrials.gov ID: NCT07271615
What this study is testing
- What it's testing
- The primary objective of this study is to determine the feasibility of preoperative stellate ganglion block in reducing the incidence of postoperative atrial fibrillation in patients undergoing CABG.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- more than 18 years old
- undergoing CABG
- Provide informed consent
You likely can't join if
- History of prior cardiac surgery or atrial fibrillation ablation;
- Emergency coronary artery bypass grafting (CABG);
- Concomitant cardiac procedures (e.g., congenital heart disease repair, left ventricular reconstruction, valve surgery, or aortic surgery);
- Critical preoperative status requiring mechanical or pharmacological support before CABG;
- Left ventricular ejection fraction (LVEF) \<35%;
- History of atrial fibrillation (defined as a supraventricular tachyarrhythmia characterized by rapid and irregular atrial electrical activity);
See the full eligibility criteria
- more than 18 years old
- undergoing CABG
- Provide informed consent
- History of prior cardiac surgery or atrial fibrillation ablation;
- Emergency coronary artery bypass grafting (CABG);
- Concomitant cardiac procedures (e.g., congenital heart disease repair, left ventricular reconstruction, valve surgery, or aortic surgery);
- Critical preoperative status requiring mechanical or pharmacological support before CABG;
- Left ventricular ejection fraction (LVEF) \<35%;
- History of atrial fibrillation (defined as a supraventricular tachyarrhythmia characterized by rapid and irregular atrial electrical activity);
- Significant mitral valve disease (mitral valve area \ 25%);
- Severe left atrial enlargement (left atrial anteroposterior diameter \>55 mm);
- Poorly controlled hyperthyroidism;
- Conditions requiring radiotherapy, chemotherapy, or long-term hormonal therapy;
- Patients with known clinical contraindications to stellate ganglion block (SGB).
The study team makes the final eligibility decision.
Where it's taking place
- Xi'an, Shaanxi, China
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Xi'an, Shaanxi, China. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.